Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Mark Yarchoan MD

Mark Yarchoan MD

Associate Professor of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medicine, Baltimore, Maryland

Mark Yarchoan, MD, is an Associate Professor of Medical Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore Maryland. Dr. Yarchoan runs an NCI-funded laboratory focused on developing novel immunotherapies for hepatobiliary cancers. He also leads multiple clinical trials of immunotherapy agents for hepatobiliary cancers.


Dr. Yarchoan reports research grants (to Johns Hopkins) from Genentech, Bristol-Myers Squibb, and Incyte and consulting fees from Genentech, Exelixis, Eisai, AstraZeneca, Replimune, Hepion, and Lantheus.